Reformulation improves adherence by reducing pill burden and side effects, enhancing real-world usability and align therapies with diverse patient needs.
- Regulatory Attention To Human Factors: How Much Is There?
- Gaining An Edge In GLP-1 Production
- Transendocardial Cell Delivery In Post‑Acute Myocardial Infarction
- Where Drug Delivery Falls Short And What The Industry Should Do Next
- BCS Class IV: Rescuing Hard To Deliver Molecules With Nanoformulation
- Patient-Centric Drug Delivery: Do Possible And Preferable Always Align?
- Expanding The IV → SC Framework: What Reformulation Really Means
- AI: The Inflection Point In Retinal Drug Discovery, Development, And Delivery
ON-DEMAND WEBINARS
Gain insights pertinent to efficient and effective drug development. Understand and execute a risked-based critical thinking approach related to injectable drug packaging and delivery.
What if a formulation that removed the need for cold chain distribution was possible? Explore the formulation of vaccines and manufacturing considerations for dry powder inhaled vaccines.
Discover how PBPK models combined with in vitro tools and solubility enhancement expertise can be used to identify and mitigate absorption risks in early drug development.
Strengthen risk mitigation strategies while ensuring regulatory alignment. Gain valuable insights into best practices and proactive approaches for building a robust and future-ready CCS.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![gettyimages-1305313838-170667a]( "Ophthalmic Formulation Development: Inside Ophthalmic Preparation")
Ophthalmic Formulation Development: Inside Ophthalmic PreparationUnderstand why the demand for CDMOs with experience in the formulation of ophthalmic products is on the rise.
-
![Evonik]( "Benefits Of Microparticle Technology For Oral Drug Solubility Enhancement")
Benefits Of Microparticle Technology For Oral Drug Solubility EnhancementSpray-dried dispersions, hot-melt extrusion, and solubilizing excipients are common solubility enhancement techniques, but new developments to maximize amorphous solid dispersion benefits are needed.
-
![Telehealth virtual ipad elderly]( "Hospital To Home: What It Means For Patients, Providers And Medical Devices")
Hospital To Home: What It Means For Patients, Providers And Medical DevicesHealthcare is shifting homeward. With telehealth, connected devices, and user-friendly design, patients and caregivers now deliver hospital-level care safely and effectively outside clinical settings.
-
![West]( "Streamlining Primary Container And Device Selection With Predictive Calculations")
Streamlining Primary Container And Device Selection With Predictive CalculationsExpolore a theoretical approach to complement experimental approaches to more quickly select a packaging and delivery system for your drug product.
-
![GettyImages-1462345800-robotics-vial-manufacturing]( "Robotics And AI In Pharma: Driving The Next Wave Of Innovation")
Robotics And AI In Pharma: Driving The Next Wave Of InnovationAdopting AI and robotics enhance sterility and regulatory compliance and enable real-time decision-making and reduce human-borne contamination, ensuring the safe production of complex therapies.
-
![Wooden blocks PFAS-GettyImages-2145498657]( "PFAS In Medical Devices: Expert Insights On Frequently Asked Questions")
PFAS In Medical Devices: Expert Insights On Frequently Asked QuestionsWatch to learn more about PFAs in medical devices, covering environmental concerns, health risks, testing, alternatives and management strategies with Shalene Thomas of Battelle.
-
![GettyImages-1096502334-lab-microscope-research]( "Selective Crystallization Of A Novel Polymorph")
Selective Crystallization Of A Novel PolymorphDiscover how applied rigorous characterization standards and expert knowledge of critical water activity enabled the isolation of a previously undiscovered and uncharacterized polymorph.
-
![iStock-1268181219-glass-vial-packaging-sterile]( "Container Closure Integrity: A Risk-Based Approach")
Container Closure Integrity: A Risk-Based ApproachContainer closure integrity is essential to protecting drug product and satisfying regulatory agencies. A risk-based approach enables creation of a robust data file for timely approval of regulatory applications.
-
![Enabling Long Lasting Clinical Outcomes In Coronary Stenting]( "Enabling Long Lasting Clinical Outcomes In Coronary Stenting")
Enabling Long Lasting Clinical Outcomes In Coronary StentingPolyester amides (PEAs) bring several desired and differentiating properties to drug-eluting stent (DES) applications for treating coronary artery disease (CAD).
-
![Injection Vials GettyImages-125930642]( "The Importance Of Understanding Materials In Medical Product Development")
The Importance Of Understanding Materials In Medical Product DevelopmentExplore considerations for the series of characterizations necessary to ensure the efficacy of a packaging or device component and final drug delivery system.
TOM'S TAKES ON DRUG DELIVERY
TALKING WITH TOM VIDEOCASTS
Fran offers keen industry and technical insights exclusively on Drug Delivery Leader.
DELIVERED BY DEGRAZIO
-
![Delivered _by _DeGrazio_Logo_Color_2]( "6 Packaging And Delivery Challenges For Biologic Therapies")
6 Packaging And Delivery Challenges For Biologic TherapiesIn this article, Fran DeGrazio identifies six aspects of biologics-based therapy packaging and delivery that, if addressed, may help to ensure successful product development and lifecycle management. They include 1) chemical compatibility with device functionality, 2) long-acting formulations, 3) product stability, 4) primary packaging and device integration, 5) cold storage, and 6) higher concentrations and viscosities.
FREE EBOOK: COMBINATION PRODUCTS
Combination products provide significant avenues for increasing patient adherence and overall efficacy. This collection outlines the opportunity and identifies strategies for gaining regulatory approval.
